The purpose of this study is to measure the effect of ranolazine on ETT (exercise treadmill
test) exercise duration in four ethnic subgroups with established coronary artery disease and
risk factor(s) for the metabolic syndrome: Caucasian, African American, Southeast Asian and
East Indian.